Digest Network How does it work
Network
/
Society
Fu
Not verified

Fujirebio

What we write about

BiotechnologyHealthIndustriaMedical and healthSanità

14 Press releases

View all press releases
05/02/2026
Labour market
Industria
Biotechnology
Pharmaceuticals
Medical and health
Sanità
Health
Psychiatry
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
Source
Fujirebio
Issuer
Business Wire
1.00
0
28/01/2026
Sanità
Pharmaceuticals
Oncology
Psychiatry
Medical and health
HIV, AIDS and autoimmune disorders
Biotechnology
Medicine - various
Scienza
Health
Industria
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
Source
Fujirebio
Issuer
Business Wire
1.00
0
14/01/2026
Biotechnology
Sanità
Health
Pharmaceuticals
Labour market
Notice Concerning Change of Representative Executive Officer
Source
Fujirebio
Issuer
Business Wire
1.00
0
23/06/2025
Scienza
Finance
Associations / Professional
Biotechnology
Health
stock market
Industria
Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries
Source
Fujirebio
Issuer
Business Wire
1.00
0
05/06/2025
Labour market
Industria
Health
HIV, AIDS and autoimmune disorders
Scienza
Pharmaceuticals
Biotechnology
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
Source
Fujirebio
Issuer
Business Wire
1.00
0
04/06/2025
Industria
Psychiatry
Health
Medical and health
Biotechnology
Sanità
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only
Source
Fujirebio
Issuer
Business Wire
1.00
0
17/05/2025
Industria
Biotechnology
Health
Medical and health
Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease
Source
Fujirebio
Issuer
Business Wire
1.00
0
23/04/2025
Multimedia
Industria
Health
HIV, AIDS and autoimmune disorders
Scienza
Pharmaceuticals
Biotechnology
Grant Award from GHIT Fund for Development of an Ultrasensitive Urine Test for Tuberculosis
Source
Fujirebio
Issuer
Business Wire
1.00
0
18/03/2025
Industria
Sanità
Medical and health
HIV, AIDS and autoimmune disorders
Health
Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an Efficient Aid to Personalized HCV Therapy
Source
Fujirebio
Issuer
Business Wire
1.00
0
23/12/2024
Biotechnology
Industria
Sanità
Health
Oncology
Scienza
Labour market
Fujirebio and Eisai Enter into Memorandum of Understanding for Joint Research and Social Implementation of Blood-based Biomarkers in the Field of Neurodegenerative Diseases
Source
Fujirebio
Issuer
Business Wire
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0